Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Hexarelin

Examorelin, HEX

Quick Stats
Studies 233
Trials 61
Score 1
2005 pubmed 34 citations

Pro-VGF-derived peptides induce penile erection in male rats: Involvement of paraventricular nitric oxide.

Succu. Salvatora S; Mascia. Maria Stefania MS; Melis. Tiziana T; Sanna. Fabrizio F; Melis. Maria Rosaria MR; Possenti. Roberta R; Argiolas. Antonio A

Key Findings

  • VGF(588-617) and related C‑terminal peptides trigger penile erection when injected into the paraventricular nucleus of male rats.
  • The erection effect is tied to a rise in nitric‑oxide production in that brain area.
  • Inhibiting nitric‑oxide synthase (with l‑NAME) or blocking oxytocin receptors reduces or eliminates the erection response.

Practical Outcomes

  • These results show a brain‑based mechanism for sexual function that involves nitric‑oxide and oxytocin pathways, but they require direct hypothalamic injection and are not translatable to oral or peripheral use. For biohackers, the study offers little immediate actionable guidance for improving erectile health, though it may inform future drug design targeting central NO or oxytocin systems.

Summary

In rats, injecting specific short pieces of the VGF protein into a brain region that controls sexual function makes them get erections. This works because the peptides boost nitric‑oxide production there, and blocking nitric‑oxide or oxytocin signals stops the effect. The findings are limited to direct brain injections in animals, not something you can do at home.

Abstract

The effect of four peptides derived from the C-terminal portion of rat pro-VGF(556-617) (VGF(556-576), VGF(588-617), VGF(599-617), and VGF(588-597)), on penile erection and nitric oxide production in the paraventricular nucleus of the hypothalamus was studied in male rats after injecting into this hypothalamic nucleus. VGF(588-617) (0.5, 1 and 2 microg), VGF(599-617) (0.5, 2 and 5 microg) and, to a lower extent, VGF(588-597) (2 and 5 microg) induced penile erection episodes when injected into the paraventricular nucleus and concomitantly increased paraventricular nitric oxide production, while VGF(556-576) (5 microg) was ineffective. VGF(588-617)-induced nitric oxide production was reduced by N(G)-nitro-l-arginine methylester (l-NAME) (20 microg), a nitric oxide synthase inhibitor, which also reduced penile erection when injected in the paraventricular nucleus 15 min before the VGF peptide. The oxytocin receptor antagonist d(CH(2))(5)Tyr(Me)-Orn(8)-vasotocin (1 microg) also effectively reduced VGF(588-617)-induced penile erection when given into the lateral ventricles, but not when injected into the paraventricular nucleus. In both experimental conditions, d(CH(2))(5)Tyr(Me)-Orn(8)-vasotocin was unable to influence nitric oxide production in the paraventricular nucleus. The present results confirm that C-terminal pro-VGF-derived peptides induce penile erection when injected into the paraventricular nucleus and show that this effect is mediated by an increased nitric oxide production in this hypothalamic nucleus. Apparently, this causes the activation of paraventricular oxytocinergic neurons projecting to extra-hypothalamic brain areas and mediating penile erection, as found with dopamine agonists, oxytocin, excitatory amino acids and hexarelin analogue peptides.

Study Information

Provider

pubmed

Year

2005

Date

2005-08-08T00:00:00.000Z

DOI

10.1016/j.neuropharm.2005.05.015

Citations

34

References

41